An Insight Into the Acceptance and Hesitancy of COVID-19 Vaccines in Pakistan: A Cross-Sectional Survey.
acceptance
covid-19 vaccines
hesitancy
pakistan
survey
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
accepted:
09
12
2022
entrez:
11
1
2023
pubmed:
12
1
2023
medline:
12
1
2023
Statut:
epublish
Résumé
COVID-19 vaccines are found to be effective interventions to tackle COVID-19. However, the hesitancy towards its acceptance has been rising in Pakistan. This study highlights the opinion of the general population in Pakistan regarding the acceptance and hesitancy of COVID-19 vaccination. A descriptive cross-sectional survey study was conducted among Pakistanis from December 2021 to January 2022. Adult respondents that have and have not received COVID-19 vaccinations were included in this study. Data collection was obtained through questionnaires that assessed acceptance and hesitancy toward COVID-19 vaccines. Statistical analysis was performed using IBM SPSS software version 25 for Windows. We obtained 367 respondents with 333 respondents completing the questionnaire. There were 259 respondents who have been vaccinated. A total of 67.9% of responses agreed that vaccines could control the COVID-19 pandemic. The reasons for not getting vaccination were afraid of adverse effects (48.6%) and COVID-19 vaccines not being tested thoroughly (30.9%). The main reason for vaccine acceptance was awareness about vaccines (23.1%), a belief that vaccines can stop severe COVID-19 disease (16.8%), and self-protection (14.7%). Most Pakistanis agreed that vaccines could manage the pandemic. Vaccine acceptance was contributed by the awareness and belief regarding the protective effects of vaccines while vaccine hesitancy was due to the public's doubt about the vaccines' side effects and testing. The Pakistan government should focus on emphasizing knowledge about vaccines, educating the vaccines' adverse effects, and utilizing social media in doing so.
Sections du résumé
BACKGROUND
BACKGROUND
COVID-19 vaccines are found to be effective interventions to tackle COVID-19. However, the hesitancy towards its acceptance has been rising in Pakistan. This study highlights the opinion of the general population in Pakistan regarding the acceptance and hesitancy of COVID-19 vaccination.
METHODS
METHODS
A descriptive cross-sectional survey study was conducted among Pakistanis from December 2021 to January 2022. Adult respondents that have and have not received COVID-19 vaccinations were included in this study. Data collection was obtained through questionnaires that assessed acceptance and hesitancy toward COVID-19 vaccines. Statistical analysis was performed using IBM SPSS software version 25 for Windows.
RESULTS
RESULTS
We obtained 367 respondents with 333 respondents completing the questionnaire. There were 259 respondents who have been vaccinated. A total of 67.9% of responses agreed that vaccines could control the COVID-19 pandemic. The reasons for not getting vaccination were afraid of adverse effects (48.6%) and COVID-19 vaccines not being tested thoroughly (30.9%). The main reason for vaccine acceptance was awareness about vaccines (23.1%), a belief that vaccines can stop severe COVID-19 disease (16.8%), and self-protection (14.7%).
CONCLUSION
CONCLUSIONS
Most Pakistanis agreed that vaccines could manage the pandemic. Vaccine acceptance was contributed by the awareness and belief regarding the protective effects of vaccines while vaccine hesitancy was due to the public's doubt about the vaccines' side effects and testing. The Pakistan government should focus on emphasizing knowledge about vaccines, educating the vaccines' adverse effects, and utilizing social media in doing so.
Identifiants
pubmed: 36628039
doi: 10.7759/cureus.32363
pmc: PMC9826719
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e32363Subventions
Organisme : Intramural NIH HHS
ID : Z01 EB000001
Pays : United States
Informations de copyright
Copyright © 2022, Rasheed et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
BMJ. 2021 Mar 11;372:n699
pubmed: 33707182
Value Health Reg Issues. 2021 May;24:114-116
pubmed: 33545492
Am J Prev Med. 2021 Jan;60(1 Suppl 1):S77-S86
pubmed: 33189502
Front Microbiol. 2020 Jul 14;11:1526
pubmed: 32760367
Front Med (Lausanne). 2021 Dec 24;8:747819
pubmed: 35036408
Yale J Biol Med. 2022 Jun 30;95(2):177-190
pubmed: 35782469
Bull World Health Organ. 2007 Dec;85(12):963-5; discussion 966-70
pubmed: 18278257
Infect Drug Resist. 2011;4:197-207
pubmed: 22114512
J Pak Med Assoc. 2008 Feb;58(2):64-7
pubmed: 18333522
PLoS One. 2021 Apr 23;16(4):e0250555
pubmed: 33891660
PLoS One. 2021 Sep 15;16(9):e0257237
pubmed: 34525110
Vaccine. 2015 Aug 14;33(34):4161-4
pubmed: 25896383
Bull World Health Organ. 2008 Feb;86(2):140-6
pubmed: 18297169
Am J Trop Med Hyg. 2021 Sep 03;105(5):1230-1239
pubmed: 34525449
Front Med (Lausanne). 2021 Nov 24;8:668299
pubmed: 34901042
Acta Biomed. 2020 Mar 19;91(1):157-160
pubmed: 32191675
Commun Med (Lond). 2022 Feb 10;2:14
pubmed: 35603311
Andrologia. 2022 May;54(4):e14361
pubmed: 34970749